10-Q: Vocodia Holdings Reports Deepening Losses, Going Concern Doubt

Sentiment:

Quarterly Report


Vocodia Holdings Corp. reported a net loss of $4.0 million for the first half of 2025, alongside a significant increase in liabilities and substantial doubt about its ability to continue as a going concern.

Delay expectedThe company suspended sales of its DISA product in January 2024 to update its functionality, delaying customer engagement until the first half of 2025.The September 2024 Note, November 2024 Note, and December 2024 Note were all past due as of June 30, 2025, indicating delays in repayment or conversion.The company incurred liquidated damages for failure to issue common stock from the exercise of warrants in a timely manner.
Capital raiseIn May 2025, the company closed on a private offering for a Senior Secured Convertible Note (May 2025 Convertible Note) with an original principal amount of $3.33 million, receiving $275,000 in proceeds by June 30, 2025.In July 2025, the company issued an additional $122,222 principal of May 2025 Convertible Notes, receiving $100,000 in cash proceeds.Subsequent to June 30, 2025, the company commenced an offering for up to 30,000,000,000 shares of common stock at $0.0001 per share, which was qualified by the SEC on August 4, 2025.Management explicitly states plans to continue to raise funds and/or refinance indebtedness to support operations in 2025 and beyond.
Worse than expectedWorking capital deficiency significantly worsened by 166% to $5.90 million.Current liabilities increased by 150% to $5.91 million.Gross loss increased by 26% to $70,803.Incurred substantial new liabilities including $710,375 in liquidated damages payable, $1.28 million in derivative liability, and $755,618 in warrant liability.The company was delisted from the Cboe BZX Exchange due to non-compliance with listing standards.Cash balance remains critically low at $283.Accumulated deficit increased to $104.7 million.

Summary

  • Net loss for the six months ended June 30, 2025, was $4.04 million, an improvement from $8.50 million in the prior year, primarily due to reduced operating expenses.
  • Revenue significantly increased to $15,136 for the six months ended June 30, 2025, from $75 in the same period last year, following the re-engagement of customers with its updated DISA product.
  • Current liabilities surged by 150% to $5.91 million as of June 30, 2025, from $2.36 million at December 31, 2024.
  • Working capital deficiency worsened by 166% to $5.90 million as of June 30, 2025, from $2.23 million at December 31, 2024.
  • The company has an accumulated deficit of $104.7 million as of June 30, 2025.
  • Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and negative working capital.
  • The company was delisted from the Cboe BZX Exchange on September 10, 2024, and now trades on the OTC Pink Market.
  • Issued 1,256,214,474 common shares outstanding as of June 30, 2025, a significant increase from 300,213,026 shares at December 31, 2024, indicating substantial dilution.
  • Engaged in multiple convertible note issuances and warrant exercises, leading to significant derivative and warrant liabilities.
  • Incurred $710,375 in liquidated damages payable for failure to issue common stock from warrants in a timely manner.
  • CEO Brian Podolak pledged 761 Solana units as collateral for a personal loan, with proceeds partially funding company operating expenses.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including substantial doubt about its going concern ability, massive accumulated deficit, worsening working capital deficiency, and significant increases in liabilities. While revenue increased and operating expenses decreased, these improvements are overshadowed by the overall precarious financial position, delisting, and ongoing legal challenges. The massive dilution from recent and planned share issuances further diminishes shareholder value.

Positives

  • Net loss for the six months ended June 30, 2025, improved to $4.04 million from $8.50 million in the prior year.
  • Revenue increased significantly to $15,136 for the six months ended June 30, 2025, from $75 in the same period last year, indicating renewed customer engagement for the DISA product.
  • Operating expenses decreased substantially by 82% to $812,282 for the six months ended June 30, 2025, from $4,399,453 in the prior year, primarily due to reduced general and administrative, salaries, and R&D costs.
  • Recognized a gain from forgiveness of payables of $79,500 during the six months ended June 30, 2025.
  • Successfully qualified a Regulation-A Statement for a common share offering of up to 30 billion shares on August 4, 2025.

Negatives

  • Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and negative working capital.
  • Accumulated deficit increased to $104.7 million as of June 30, 2025.
  • Current liabilities increased by 150% to $5.91 million as of June 30, 2025.
  • Working capital deficiency worsened by 166% to $5.90 million as of June 30, 2025.
  • Gross loss increased by 26% to $70,803 for the six months ended June 30, 2025.
  • Incurred $710,375 in liquidated damages payable for failure to issue common stock from warrants in a timely manner.
  • Derivative expense and change in fair value of derivative liability significantly worsened to $1,128,710 for the six months ended June 30, 2025, from a gain of $115,296 in the prior year.
  • Incurred a loss on issuance of May 2025 convertible note and warrants of $756,621.
  • Experienced significant shareholder dilution, with common shares outstanding increasing from 300.2 million to 1.26 billion.
  • Delisted from the Cboe BZX Exchange due to non-compliance with minimum bid price and financial requirements, now trading on the OTC Pink Market.
  • Multiple ongoing legal proceedings, including a TCPA class action lawsuit and claims for unpaid professional fees.
  • CEO Brian Podolak used company digital assets (Solana) as collateral for a personal loan, with proceeds partially funding company operating expenses, raising corporate governance concerns.

Risks

  • Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and negative working capital.
  • Inability to obtain additional resources or refinance indebtedness could materially affect business plans, financial condition, and results of operations.
  • Digital assets (Solana, Ethereum) are subject to significant legal, commercial, regulatory, and technical uncertainty, high price volatility, custodial fees, and counterparty/cybersecurity risks.
  • Risk of losing some or all digital assets if private keys are lost or destroyed.
  • Ongoing legal disputes and litigation matters, including a putative class action lawsuit under the Telephone Consumer Protection Act (TCPA) and claims for unpaid professional fees, could result in significant damages or legal expenses.
  • Failure to maintain effective disclosure controls and procedures, or internal control over financial reporting, could harm operating results, lead to reporting failures, or negatively affect share price.
  • The company's financial statements may not be comparable to other public companies due to its election as an emerging growth company to delay adopting new accounting standards.
  • The company's common stock and warrants were delisted from the Cboe BZX Exchange and now trade on the OTC Pink Market, with no assurance of approval or continued trading on the OTCQB Venture Market.
  • Significant shareholder dilution from the issuance of common stock for debt settlements, warrant exercises, and convertible note conversions.
  • The May 2025 Convertible Note includes embedded contingent redemption features and a senior secured position against the company's assets for the investor.

Future Outlook

Management believes it will not have sufficient cash on hand to support operations for at least 12 months and intends to rely on cash from operations and equity/debt offerings. Efforts are directed towards generating positive cash flow and profitability. If additional capital is not available on reasonable terms, cost control measures, increased sales efforts, or strategic actions like company sale, joint ventures, or strategic alliances will be necessary.

Management Comments

  • Management recognizes that the Company must obtain additional resources to successfully develop its technology and implement its business plans.
  • Management plans to continue to raise funds and/or refinance our indebtedness to support our operations in 2025 and beyond. However, no assurances can be given that we will be successful.
  • If management is not able to timely and successfully raise additional capital and/or refinance indebtedness, the implementation of the Company’s business plan, financial condition and results of operations will be materially affected.
  • We believe we will not have sufficient cash on hand to support our operations for at least 12 months.
  • Our efforts are directed toward generating positive cash flow and, ultimately, profitability.

Industry Context

Vocodia operates in the highly competitive and rapidly evolving conversational AI technology sector, aiming to provide scalable enterprise AI sales and customer service solutions. The company's focus on enhancing rapport and relationship building through human-like AI voices positions it within a growing market for automated customer interaction. However, its financial struggles and delisting from a major exchange contrast sharply with the significant investment and growth seen in the broader AI industry, suggesting a failure to capitalize effectively on market trends or secure adequate funding to compete.

Comparison to Industry Standards

  • NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorized Capital Stock IncreaseCompany amended its articles of incorporation to increase the number of authorized common shares to 15,000,000,000.2025-02-28Enables significant future equity issuances, potentially leading to further shareholder dilution.
Series A Preferred Stock Voting Rights AmendmentCompany amended the Designation of the Series A Preferred Stock to restore voting rights, granting holders the right to vote on any matters brought before stockholders as a single class, with each share having 10,000 common stock votes.2025-02-24Increases the voting power of Series A Preferred Stockholders, potentially shifting control dynamics.

Legal Proceedings

  • Putative class action lawsuit under the Telephone Consumer Protection Act (TCPA) alleging prerecorded calls to a number on the National Do-Not-Call Registry.
  • Arbitration commenced by ProofPositive LLC alleging failure to pay sums due under a loan agreement, promissory note, addendum, and consulting agreement.
  • Lawsuit by MAI Voice GCO, LLC alleging breach of contract and seeking $32,090.
  • Lawsuit by Berkowitz Pollack & Brant Advisors for unpaid professional fees in the amount of $48,057.
  • Settlement agreement with Carstens, Allen & Gourley, LLP to pay $160,000 plus interest in 13 payments for unpaid attorneys' fees.
  • Liquidated damages settlement (Damages Settlement 1) of $500,000 to an investor for failure to issue common stock from warrant exercise in a timely manner.
  • Liquidated damages settlement (Damages Settlement 2) of $210,375 to an investor for failure to issue common stock from Series C warrants in a timely manner.

Related Party Transactions

  • Incurred $35,500 (Q2 2025) and $68,777 (H1 2025) in consulting services from SGT Teams, a company owned by the CEO.
  • Outstanding accounts payable balance of $13,197 due to 47 Capital Management, LLC, an entity wholly owned by the former CFO.
  • Recognized expenses of $26,000 (H1 2025) and $19,500 (Q2 2025) due to Thornhill Advisory Group, Inc., an entity majority owned by the former CFO.
  • Outstanding accounts payable balance of $38,500 due to Thornhill Advisory Group, Inc.
  • CEO Brian Podolak borrowed $55,172 in a personal loan, pledging 761 units of the company's Solana as collateral, with proceeds partially funding company operating expenses.
  • Related party payable balance of $30,876 due to CEO Brian Podolak for expenses incurred on behalf of the company.
  • CEO Brian Podolak's personal loan was amended on July 23, 2025, to increase its principal to $70,695.

Stakeholder Impact

  • Shareholders: Significant dilution from massive increases in common stock outstanding (from 300.2 million to 1.26 billion shares, with a further offering of up to 30 billion shares). Delisting from Cboe to OTC Pink Market negatively impacts liquidity and investor confidence. Potential for further value erosion due to ongoing losses, going concern doubt, and legal liabilities.
  • Creditors/Noteholders: The company has substantial outstanding convertible notes and other payables, with several notes past due. The May 2025 Convertible Note grants a senior secured position to the investor, potentially disadvantaging other creditors. Liquidated damages settlements indicate past failures to meet obligations.
  • Employees: Reduction in staff in 2024 and elimination of salaries and wages for the six months ended June 30, 2025, suggest significant workforce adjustments and potential instability.
  • Customers: Suspension of DISA product sales in 2024 for updates may have impacted customer relationships, though new customer engagement resumed in H1 2025. The TCPA lawsuit could affect customer trust and lead to regulatory scrutiny.

Next Steps

  • Management plans to continue to raise funds and/or refinance indebtedness to support operations in 2025 and beyond.
  • If capital is not available, the company will implement cost control measures, increase sales efforts, or explore strategic options like company sale, joint ventures, or strategic alliances.
  • The company intends to apply to have its common stock quoted on the OTCQB Venture Market.
  • The common share offering of up to 30,000,000,000 shares will continue for one year after qualification (August 4, 2025) or until all shares are sold.
  • The company will take all corporate action necessary to call a stockholders meeting to seek approval for the issuance of Series C Preferred Shares and Conversion Shares, as required by market rules.
  • The company will file proxy materials with the SEC and solicit stockholder votes for the Stockholder Approval.
  • If Stockholder Approval is not obtained, the company will call a meeting every ninety days thereafter until approval is secured.

Key Dates

DateDescription
2019-11-29Click Fish Media, Inc. (CFM) incorporated in Florida.
2021-04-27Vocodia Holdings Corp incorporated in Wyoming.
2022-08-01Company entered into a lending arrangement with a related party, the prior owner of Click Fish Media.
2022-08-02Vocodia purchased all outstanding shares of CFM from an owner under common ownership for $10.
2023-07-12Former employee's resignation accepted.
2023-08-28Company received a letter from an attorney representing a former employee alleging sexual harassment and wrongful termination.
2023-09-27Company amended certificate of designation to authorize 3,000 Series B Preferred Shares.
2023-10-10Plaintiff alleges receiving a prerecorded call from the Company on behalf of its customer (TCPA lawsuit).
2023-11-28Plaintiff alleges receiving a prerecorded call from the Company on behalf of its customer (TCPA lawsuit).
2023-12-16MAI Voice GCO, LLC filed a verified complaint alleging breach of contract and seeking $32,090.
2023-12-20Company entered into the December 2024 Note with a principal of $60,000.
2023-12-20An individual filed a putative class action lawsuit against a customer of the Company, later adding the Company as a party (TCPA lawsuit).
2023-12-31Fiscal year end for 2023 and comparative balance sheet date.
2024-01-01Company suspended sales of its DISA product to update functionality.
2024-01-01Company adopted ASU 2023-08 (Accounting for and Disclosure of Crypto Assets) on a prospective basis.
2024-01-01Company issued 605 shares of Series B Preferred Stock for $605,000.
2024-01-01Common shares issued for settlement of accounts payable to CEO, Chief Product Officer, and CFO's company.
2024-02-22Common Stock, Series A Warrants, and Series B Warrants began trading on the BZX Exchange.
2024-02-26Company completed its initial public offering (IPO) of 1,400,000 units at $4.25 per unit.
2024-02-291,910 shares of Series B Preferred Stock converted into 691,404 shares of common stock upon IPO closing.
2024-03-31End of first fiscal quarter for 2024.
2024-05-31ProofPositive LLC commenced arbitration against the Company, Brian Podolak, and his wife.
2024-06-14Company received a letter from Cboe BZX Exchange notifying of delisting decision.
2024-06-30End of second fiscal quarter for 2024 and comparative balance sheet date.
2024-08-02Company issued a Certificate of Designation of Series C Convertible Preferred Stock.
2024-08-02Company issued a Certificate of Designation of Series D Preferred Stock.
2024-08-08Appeal hearing held before a two-member Panel regarding Cboe delisting.
2024-08-12Carstens, Allen & Gourley, LLP commenced an action against the Company in Texas Civil Court.
2024-09-06Company received notice that the Panel rejected its appeal and determined to delist its securities from Cboe.
2024-09-10Trading of the Company's Common Stock and Warrants suspended and delisted from Cboe.
2024-09-11Company's common stock began trading on the OTC Pink Market.
2024-09-18Company entered into the September 2024 Note with a principal of $105,300.
2024-10-15Parties agreed to attend mediation for the TCPA class action lawsuit.
2024-11-13Company entered into the November 2024 Note with a principal of $57,500.
2024-12-15Company moved out of its corporate offices, ending a long-term lease.
2024-12-16Company issued a note payable of $40,000 to pay professional fees.
2024-12-31Fiscal year end for 2024 and comparative balance sheet date.
2025-01-01Company began engaging new customers with its DISA product.
2025-01-17December 2024 Note amended to increase principal to $96,000.
2025-02-24Company amended the Designation of the Series A Preferred Stock to restore voting rights.
2025-02-28Company amended its articles of incorporation to increase authorized common shares to 15,000,000,000.
2025-03-03Company entered into the March 2025 Note 1 with a principal of $56,000.
2025-03-06Company entered into a liquidated damages settlement (Damages Settlement 1) of $500,000.
2025-03-07Company entered into the March 2025 Note 2 with a principal of $30,000.
2025-03-12Company entered into the March 2025 Note 4 with a total principal of $285,714.
2025-03-18Company entered into the March 2025 Note 3 with a principal of $30,000.
2025-03-20Company entered into a liquidated damages settlement (Damages Settlement 2) of $210,375.
2025-03-31End of first fiscal quarter for 2025.
2025-04-01Company reached a settlement agreement with Carstens, Allen & Gourley, LLP to pay $160,000 plus interest.
2025-05-13Company closed on a private offering for the May 2025 Convertible Note with a principal of $3,333,333.
2025-05-13Holder of the November 2024 Note converted $8,688 principal and $4,312 accrued interest into 37,142,857 shares of common stock.
2025-05-21Holder of the November 2024 Note converted $16,100 principal into 46,000,000 shares of common stock.
2025-06-30End of second fiscal quarter for 2025 and current balance sheet date.
2025-07-07Company issued 1,022,900 shares of common stock for partial settlement of Damages Settlement 1 (subsequent event).
2025-07-08Holder of the November 2024 Note elected to convert remaining $32,712 principal into 337,314,286 shares of common stock (subsequent event).
2025-07-09Holder of the September 2024 Note converted $4,224 principal to 40,382,256 shares of common stock (subsequent event).
2025-07-11Company issued 56,664,000 shares of common stock due to cashless exercise of 1,000 Series C warrants (subsequent event).
2025-07-15Company issued 47,000,000 shares of common stock for partial settlement of Damages Settlement 2 (subsequent event).
2025-07-17Company issued 113,329,334 shares of common stock due to cashless exercise of 2,000 Series B warrants (subsequent event).
2025-07-21Holder of the December 2024 Note elected to convert $2,850 principal to 95,000,000 shares of common stock (subsequent event).
2025-07-23CEO Brian Podolak's personal loan amended to increase principal to $70,695 (subsequent event).
2025-07-31Company issued $122,222 principal of May 2025 Convertible Notes, receiving $100,000 cash (subsequent event).
2025-08-01Holder of the November 2024 Note elected to convert $2,250 principal to 75,000,000 shares of common stock (subsequent event).
2025-08-04Offering Statement on Form 1-A qualified by the SEC for common share offering (subsequent event).
2025-08-04Holder of the December 2024 Note elected to convert $3,150 principal to 105,000,000 shares of common stock (subsequent event).
2025-08-12Holder of the November 2024 Note elected to convert remaining $32,712 principal into 337,314,286 shares of common stock (subsequent event).
2025-08-13Holder of the December 2024 Note elected to convert $27,690 principal to 414,000,000 shares of common stock (subsequent event).
2025-08-21Company issued 148,748,250 shares of common stock due to exercise of 875 Series B warrants (subsequent event).
2025-09-02Company issued 1,022,900 shares of common stock for partial settlement of Damages Settlement 1 (subsequent event).
2025-09-26Registrant had 3,558,352,600 shares of common stock outstanding.
2025-09-29Date of filing of this Quarterly Report on Form 10-Q.

Recommendation

strong sell

The company faces severe financial distress, evidenced by substantial doubt about its ability to continue as a going concern, a massive accumulated deficit of over $104 million, and a rapidly worsening working capital deficiency. While revenue saw a percentage increase, the absolute numbers remain negligible, and gross loss is increasing. The company has incurred significant new liabilities from derivative instruments, warrants, and liquidated damages due to past failures. The delisting from a major exchange to the OTC Pink Market severely limits liquidity and investor confidence. Furthermore, the ongoing and planned massive dilution of common stock, with shares outstanding increasing from 300 million to over 1.2 billion and a new offering of up to 30 billion shares, will drastically erode per-share value. Multiple legal proceedings and related-party transactions, including the CEO pledging company assets for a personal loan, raise serious corporate governance concerns. Given the precarious financial position, high risk of insolvency, and extreme dilution, a strong sell recommendation is warranted.

Keywords

Vocodia Holdings, VHAI, AI technology, Conversational AI, SEC filing, 10-Q, Financial results, Net loss, Going concern, Liquidity, Capital raise, Convertible notes, Warrants, Share dilution, Digital assets, Solana, Ethereum, Legal proceedings, Delisting, OTC Markets, Corporate governance, Risk management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.